5916 Federal Register / Vol. 89, No. 20 / Tuesday, January 30, 2024 / Notices 

The conditions for issuance of a waiver 

under 21 CFR 10.19 are met. 

Dated: January 25, 2024. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2024–01797 Filed 1–29–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice of Interest Rate on Overdue 

Debts 

Section 30.18 of the Department of 

Health and Human Services’ claims 

collection regulations (45 CFR part 30) 

provides that the Secretary shall charge 

an annual rate of interest, which is 

determined and fixed by the Secretary 

of the Treasury after considering private 

consumer rates of interest on the date 

that the Department of Health and 

Human Services becomes entitled to 

recovery. The rate cannot be lower than 

the Department of Treasury’s current 

value of funds rate or the applicable rate 

determined from the ‘‘Schedule of 

Certified Interest Rates with Range of 

Maturities’’ unless the Secretary waives 

interest in whole or part, or a different 

rate is prescribed by statute, contract, or 

repayment agreement. The Secretary of 

the Treasury may revise this rate 

quarterly. The Department of Health and 

Human Services publishes this rate in 

the Federal Register. 

The current rate of 12 3⁄8%, as fixed 

by the Secretary of the Treasury, is 

certified for the quarter ended December 

31, 2023. This rate is based on the 

Interest Rates for Specific Legislation, 

‘‘National Health Services Corps 

Scholarship Program (42 U.S.C. 

254o(b)(1)(A))’’ and ‘‘National Research 

Service Award Program (42 U.S.C. 

288(c)(4)(B)).’’ This interest rate will be 

applied to overdue debt until the 

Department of Health and Human 

Services publishes a revision. 

David C. Horn, 

Director, Office of Financial Policy and 

Reporting, 

[FR Doc. 2024–01817 Filed 1–29–24; 8:45 am] 

BILLING CODE 4150–048–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; AD/ADRD 

Management Evolution. 

Date: March 19, 2024. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maurizio Grimaldi, M.D., 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

7201 Wisconsin Avenue, Gateway Bldg., 

Suite 2C218, Bethesda, MD 20892, 301–496– 

9374, grimaldim2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 25, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–01816 Filed 1–29–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, PAR 

Panel Hypersensitivity, Allergies and 

Mucosal Immunology, February 08, 

2024, 10:00 a.m. to February 08, 2024, 

07:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, which was 

published in the Federal Register on 

January 19, 2024, 89 FR 3675, Doc 

2024–00948. 

This meeting is being amended to 

change the SRO Contact Person from 

Velasco Cimica, Ph.D., to Marcus 

Ferrone, Ph.D., Center for Scientific 

Review, National Institutes of Health, 

6701 Rockledge Drive, Bethesda, MD 

20892, Marcus.Ferrone@nih.gov, 301– 

402–2371. This amendment supersedes 

the previous amendment because the 

name of the meeting was mistakenly 

omitted in the first amendment and to 

provide the new SRO’s contact 

information. The meeting is closed to 

the public. 

Dated: January 24, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–01778 Filed 1–29–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Cure 

Glomerulonephropathy (CureGN) Review. 

Date: March 19, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Paul A. Rushing, Ph.D., 

Scientific Review Officer, Review Branch, 

Division of Extramural Activities, NIDDK, 

National Institutes of Health, Room 7345, 

6707 Democracy Boulevard, Bethesda, MD 

20892–5452, (301) 594–8895, rushingp@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 


khammond on DSKJM1Z7X2PROD with NOTICES